
TPST
Healthcare · Biotechnology · $7.6M market cap
$0.3819-0.00 (-0.3%)Nov 13, 4:21 PM EST
Next report
Time not confirmed
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · +8.6% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 18, 2026 · upcoming | Time not confirmed | -0.32 | -0.79 | -146.9% |
| Aug 13, 2026 | After the close | -0.30 | -0.34 | -13.3% |
| May 15, 2026 | Time not confirmed | -0.28 | -0.50 | -80.0% |
| Mar 30, 2026 | Before the open | -0.62 | -0.62 | 0.0% |
| Nov 5, 2025 | Before the open | -3.27 | -0.79 | +75.8% |
| Aug 11, 2025 | After the close | -3.23 | -2.07 | +35.9% |
| May 13, 2025 | After the close | -3.29 | -3.16 | +4.0% |
| Mar 17, 2025 | Before the open | -0.24 | -0.31 | -26.5% |
| Nov 12, 2024 | After the close | -4.58 | -5.33 | -16.4% |
| Aug 8, 2024 | After the close | -5.33 | -5.46 | -2.4% |
| May 9, 2024 | After the close | -4.94 | -4.68 | +5.3% |
| Mar 19, 2024 | After the close | -0.39 | -0.38 | +2.6% |
| Nov 8, 2023 | After the close | -7.19 |
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma that completed Phase 2 clinical trial; and TPST-1495, a…
| -6.24 |
| +13.2% |
| Aug 10, 2023 | After the close | -7.54 | -7.02 | +6.9% |
| May 10, 2023 | After the close | -8.54 | -7.15 | +16.3% |
| Mar 22, 2023 | After the close | -0.76 | -0.63 | +17.1% |
| Nov 8, 2022 | Before the open | -9.88 | -8.58 | +13.2% |
| Aug 15, 2022 | Before the open | -12.00 | -10.27 | +14.4% |
| May 13, 2022 | Before the open | -1.12 | -1.18 | -5.4% |
| Mar 29, 2022 | After the close | -16.03 | -7.93 | +50.5% |
| Nov 10, 2021 | After the close | -13.61 | -15.73 | -15.6% |
| Aug 12, 2021 | After the close | -11.37 | -13.69 | -20.4% |
| May 13, 2021 | Before the open | -5.25 | -6.60 | -25.7% |
| Mar 29, 2021 | Before the open | -5.15 | -5.85 | -13.6% |
| Nov 9, 2020 | Before the open | -6.90 | -5.10 | +26.1% |
| Aug 10, 2020 | Before the open | -8.20 | -8.40 | -2.4% |
| May 8, 2020 | Before the open | -10.00 | -9.75 | +2.5% |
| Mar 11, 2020 | Before the open | -12.18 | -13.05 | -7.1% |
| Nov 13, 2019 | Before the open | -12.38 | -13.05 | -5.4% |
| Aug 12, 2019 | Before the open | -12.12 | -11.10 | +8.4% |
| May 15, 2019 | Before the open | -10.55 | -11.70 | -10.9% |
| Mar 29, 2019 | Before the open | -12.85 | -12.30 | +4.3% |
| Nov 9, 2018 | After the close | -4.05 | -0.79 | +80.5% |
| Aug 9, 2018 | After the close | -0.27 | -3.30 | -1122.2% |
| May 3, 2018 | After the close | -0.28 | -3.15 | -1025.0% |
| Mar 15, 2018 | After the close | -61.95 | -54.00 | +12.8% |